ArticleTurkish journal of medical sciences2020

CD34+ hematopoietic progenitor cell dose as a predictor of engraftment and survival in multiple myeloma patients undergoing autologous stem cell transplantation

Elifcan Aladağ Karakulak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.